These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37497898)

  • 1. Discriminant Analysis Using Gabor Filter Sets for Lobular Endocervical Glandular Hyperplasia: Numerical Interpretation of Nuclear Atypia by Gabor Filter Features.
    Kimura F; Ohshima K; Shirai K; Kanai R; Sonohara M; Ishii K
    Acta Cytol; 2023; 67(5):539-549. PubMed ID: 37497898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant analysis and interpretation of nuclear chromatin distribution and coarseness using gray-level co-occurrence matrix features for lobular endocervical glandular hyperplasia.
    Kanai R; Ohshima K; Ishii K; Sonohara M; Ishikawa M; Yamaguchi M; Ohtani Y; Kobayashi Y; Ota H; Kimura F
    Diagn Cytopathol; 2020 Aug; 48(8):724-735. PubMed ID: 32374944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia.
    Kimura F; Kobayashi T; Kanai R; Kobayashi Y; Yuhi O; Ota H; Yamaguchi M; Yokokawa Y; Uehara T; Ishii K
    Diagn Cytopathol; 2019 Jun; 47(6):553-563. PubMed ID: 30761780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of adenocarcinoma in situ arising in lobular endocervical glandular hyperplasia indicating localization of mucin on the cluster surface as an early cytological finding of malignant transformation.
    Okuyama R; Hashimoto H; Miura T; Sugita M; Arai M; Tsunoda H; Sasajima Y; Horiuchi H
    Diagn Cytopathol; 2017 Sep; 45(9):842-847. PubMed ID: 28449203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic Cytological Findings of Lobular Endocervical Glandular Hyperplasia Associated with Adenocarcinoma of the Uterine Cervix.
    Ishii S; Ito T; Yamada M; Yamazaki N; Ikebata K; Fujiyama J; Furuta N; Komatsu K; Takeuchi K; Sugiyama Y; Takazawa Y
    Acta Cytol; 2020; 64(6):556-562. PubMed ID: 32814324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
    Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
    Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
    Takatsu A; Shiozawa T; Miyamoto T; Kurosawa K; Kashima H; Yamada T; Kaku T; Mikami Y; Kiyokawa T; Tsuda H; Ishii K; Togashi K; Koyama T; Fujinaga Y; Kadoya M; Hashi A; Susumu N; Konishi I
    Int J Gynecol Cancer; 2011 Oct; 21(7):1287-96. PubMed ID: 21685796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and management of lobular endocervical glandular hyperplasia.
    Miyamoto T; Kobara H; Shiozawa T
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3056-3067. PubMed ID: 36177810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
    Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
    Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited frequency of malignant change in lobular endocervical glandular hyperplasia.
    Kobara H; Miyamoto T; Ando H; Asaka R; Takatsu A; Ohya A; Asaka S; Shiozawa T
    Int J Gynecol Cancer; 2020 Oct; 30(10):1480-1487. PubMed ID: 32883699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection.
    Nara M; Hashi A; Murata S; Kondo T; Yuminamochi T; Nakazawa K; Katoh R; Hoshi K
    Gynecol Oncol; 2007 Aug; 106(2):289-98. PubMed ID: 17540439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of minimal deviation adenocarcinoma: possible clinical link to lobular endocervical glandular hyperplasia as its origin.
    Sugihara T; Nakagawa S; Sasajima Y; Matsumoto Y; Takeshita S; Ayabe T
    J Obstet Gynaecol Res; 2015 Mar; 41(3):483-7. PubMed ID: 25257165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tall-columnar glandular cells in SurePath™ liquid-based cytology Pap sample: Learning from mimics/pitfalls.
    Gupta N; Jain V; Srinivasan R; Singh T
    Cytopathology; 2024 Jul; 35(4):510-514. PubMed ID: 38712698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
    Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
    Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
    Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
    Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
    Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
    Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
    Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
    Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).
    Takatsu A; Miyamoto T; Fuseya C; Suzuki A; Kashima H; Horiuchi A; Ishii K; Shiozawa T
    Virchows Arch; 2013 Jun; 462(6):645-51. PubMed ID: 23645358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
    Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
    Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.